Local Substudy Associated to the International Study MO19390 to Determine the BRCA1 Gene mRNA Expression as a Predictive Marker of Response to Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 08 Jul 2015
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin; Docetaxel; Gemcitabine; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Roche
- 20 Jan 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 17 Jun 2008 Status changed from initiated to recruiting according to ClinicalTrials.gov.
- 09 Apr 2008 New trial record.